GlassScriptPhysician profile
Thais A Fortes
NPI 1710399902
$1,105.91
in general payments reported to CMS, 2019-2025
13 companies · $50.74 in 2025
The $50.74 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $790 · 2020: $44.92 · 2022: $36.76 · 2023: $184 · 2025: $50.74.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $235.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $234.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $482.68 | 2019 | |
| Stryker Corporation | $181.09 | 2019-2023 | Spy-Phi System |
| Hologic INC | $114.14 | 2019 | |
| Heron Therapeutics, INC. | $112.14 | 2023 | Zynrelef |
| Ethicon US, LLC | $50.74 | 2025 | Megadyne, Harmonic |
| Medtronic, INC. | $32.29 | 2022-2023 | Ligasure |
| E.R. Squibb & Sons, L.L.C. | $25.06 | 2019 | |
| Smith+Nephew, INC. | $24.44 | 2023 | Stravix |
| Allergan, INC. | $19.52 | 2022 | |
| Sanofi-Aventis U.S. LLC | $18.89 | 2019 | |
| Mallinckrodt Hospital Products INC. | $18.75 | 2020 | |
| Medtronic USA, INC. | $14.33 | 2020 | |
| Lsi Solutions INC | $11.84 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thais Fortes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.